10x Genomics to Report First Quarter 2026 Financial Results on May 7, 2026
10x Genomics (Nasdaq: TXG) will report first quarter 2026 financial results for the period ended March 31, 2026 on May 7, 2026 after market close.
Rhea-AI Summary
10x Genomics (Nasdaq: TXG) will report first quarter 2026 financial results for the period ended March 31, 2026 on May 7, 2026 after market close. A public conference call and live webcast will begin at 1:30 p.m. PT / 4:30 p.m. ET to discuss results, business developments and outlook.
The company said the news release with financial results will be posted on its investor website prior to the call, and the webcast will be archived for at least 45 days.
Positive
- None.
Negative
- None.
Details
News Market Reaction – TXG
On Apr 16, the first trading day after this news, TXG closed 0.43% below the previous close.
Data tracked by StockTitan Argus for the Apr 16 session.
Key Figures
- Quarter end date
- March 31, 2026
- First quarter 2026 reporting period
- Earnings release date
- May 7, 2026
- Scheduled Q1 2026 financial results release after market close
- Conference call time PT
- 1:30 p.m.
- Public conference call start, Pacific Time
- Conference call time ET
- 4:30 p.m.
- Public conference call start, Eastern Time
- Webcast replay period
- 45 days
- Archived replay availability after event
Previous Earnings date Reports
-
Announced timing and webcast details for Q4 and full-year 2025 results.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Interested parties may access a live webcast of the fireside chat on the "Investors" section of the company's website at: https://investors.10xgenomics.com/. The webcast will be archived and available for replay for at least 45 days after the event.
About 10x Genomics
10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated research solutions include instruments, consumables and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems at a resolution and scale that matches the complexity of biology. Our products are behind breakthroughs in oncology, immunology, neuroscience and more, fueling powerful discoveries that are transforming the world's understanding of health and disease. To learn more, visit 10xgenomics.com or connect with us on LinkedIn, X, Facebook, Bluesky or YouTube.
Disclosure Information
10x Genomics uses filings with the Securities and Exchange Commission, its website (https://www.10xgenomics.com/), press releases, public conference calls, public webcasts and its social media accounts as means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.
Contacts
Investors: investors@10xgenomics.com
Media: media@10xgenomics.com
View original content:https://www.prnewswire.com/news-releases/10x-genomics-to-report-first-quarter-2026-financial-results-on-may-7-2026-302743619.html
SOURCE 10x Genomics, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.